Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Vomiting 4Nausea 4Sarcoma 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 4Therapeutics 3Immunoenzyme Techniques 3Early Intervention, Educational 3Cyclophosphamide 3Biopsy 3saponin QA-21V1 2exemestane 2Vorinostat 2Standard of Care 2Psychiatric Rehabilitation 2Physical Therapy Modalities 2Letrozole 2Immunologic Techniques 2Gene Expression Profiling 2Fluorodeoxyglucose F18 2Flow Cytometry 2Doxorubicin 2Docetaxel 2Chemotherapy, Adjuvant 2Bevacizumab 2Anastrozole 2Acupuncture Therapy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2pegfilgrastim 1iso-sulfan blue 1alovudine 1Zoledronic Acid 1Trastuzumab 1Tomography, Emission-Computed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms, Male × Palonosetron × Clear all
NCT00343863 2017-07-11

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

University of Washington

Phase NA Completed
41 enrolled 12 charts
Breast

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡